| Indicators | Baseline | Post Intervention |
| |||||||
| 6 - 8 N (%) | 9 - 11 N (%) | 12 - 24 N (%) | 6 - 24 N (%) | 6 - 8 N (%) | 9 - 11 N (%) | 12 - 24 N (%) | 6 - 24 N (%) | p-value | ||
| cMMF |
|
|
|
|
|
|
|
|
| |
| Met | 3 (7.5) | 7 (17.5) | 5 (12.5) | 15 (37.5) | 3 (7.5) | 7 (17.5) | 14 (35.0) | 25 (62.5) | 0.001 | |
| Not Met | 3 (7.5) | 3 (7.5) | 15 (47.5) | 25 (62.5) | 3 (7.5) | 3 (7.5) | 10 (25.0) | 15 (37.5) |
| |
| Total | 6 (15.0) | 10 (25.0) | 25 (60.0) | 40 (100.0) | 6 (15.0) | 10 (25.) | 24 (60.0) | 40 (100) |
| |
| dMDD |
|
|
|
|
|
|
|
|
| |
| Met | 5 (12.5) | 9 (22.5) | 7 (17.4) | 21 (52.5) | 5 (12.5) | 9 (22.5) | 18 (45) | 32 (80) | 0.001 | |
| Not Met | 1 (1.2) | 1 (1.2) | 17 (20.2) | 19 (47.5) | 1 (2.5) | 1 (2.5) | 6 (15) | 8 (20) |
| |
| Total | 6 (13.7) | 10 (23.7) | 24 (37.6) | 40 (100.0) | 6 (15.0) | 10 (25.) | 24 (60.0) | 40 (100) |
| |
| eMAD |
|
|
|
|
|
|
|
|
| |
| Met | 3 (7.5) | 7 (10.0) | 4 (17.5) | 11 (35) | 4 (12.5) | 7 (10.0) | 13 (20) | 24 (60.0) | 0.001 | |
| Not Met | 3 (7.5) | 3 (15.0) | 20 (42.5) | 29 (65.0) | 2 (2.5) | 3 (14.5) | 11 (40.0) | 16 (40.0) |
| |
| Total | 6 (15.0) | 10 (25.0) | 24 (60.0) | 40 (100.0) | 6 (15.0) | 10 (24.5 | 24 (60.0) | 40 (100) |
| |